Skip to content

Child and Adolescent OCD Outcomes From Exposure and Response Prevention Video Teletherapy Treatment

Effectiveness of Video Teletherapy in Treating Child and Adolescent Obsessive-Compulsive Disorder With Exposure and Response Prevention: a Retrospective Longitudinal Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06466447
Enrollment
2173
Registered
2024-06-20
Start date
2020-07-23
Completion date
2024-05-03
Last updated
2024-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obsessive-Compulsive Disorder

Keywords

exposure and response prevention, digital behavioral health, remote treatment, video therapy, children, adolescents

Brief summary

This is a naturalistic, observational study of children and adolescents with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy.

Interventions

Exposures and response prevention therapy (a type of cognitive-behavioral therapy for obsessive-compulsive disorder), delivered in real-time by therapists remotely via video. The treatment was augmented by between-session text messaging.

Sponsors

NOCD
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
4 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* obsessive-compulsive disorder

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
Dimensional Obsessive-Compulsive Scalechange from pre-treatment to post-treatment (after 11 weeks)self-rated psychometric instrument to measure symptom severity of multiple OCD subtypes (score range: 0-80)

Secondary

MeasureTime frameDescription
Depression Anxiety and Stress Scale (DASS-21)pre-treatment, after 4 weeks, and post-treatment (after 11 weeks)self-rated psychometric instrument to measure depression, anxiety, and stress (score range: 0-63)

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026